- AU$116.73m
- AU$105.31m
- AU$111.52m
Australia's SomnoMed hits 11-month low on weak HY results
Brief: Somnomed Remains Optimistic About Trading Activity Levels And Outlook For Second Half Of Fy22
Australia Stock Exchange release from SOMNOMED : SomnoMed introduces Rest Assure
Australia Stock Exchange release from SOMNOMED : Investor Presentation
Australia Stock Exchange release from SOMNOMED : PRE_NR Ends: 09:53:56
Australia Stock Exchange release from SOMNOMED : PRE_NR Ends: 09:51:41
Australia Stock Exchange release from SOMNOMED : Revenues on track despite COVID-19 disruptions
Australia Stock Exchange release from SOMNOMED : Half Yearly Report and Accounts
Australia Stock Exchange release from SOMNOMED : PRE_NR Ends: 09:48:26
Australia Stock Exchange release from SOMNOMED : Half-year financial results Investor conference call details
Australia Stock Exchange release from SOMNOMED : World first technology enabled oral appliance
Australia Stock Exchange release from SOMNOMED : PRE_NR Ends: 10:00:51
Brief: Somnomed Revenue Of A$18.3 Million For Q2
Australia Stock Exchange release from SOMNOMED : Appendix 4C Cash Flow Report
Australia Stock Exchange release from SOMNOMED : PRE_NR Ends: 09:57:35
Australia Stock Exchange release from SOMNOMED : North America Q2 revenue 36% amid regional variability
Australia Stock Exchange release from SOMNOMED : PRE_NR Ends: 09:53:25
Australia Stock Exchange release from SOMNOMED : Notification regarding unquoted securities - SOM
Australia Stock Exchange release from SOMNOMED : Change of Director's Interest Notice